90 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
Park Plaza, Suite 1750
Irvine, CA 92614
May 14, 2024
Dear Stockholders:
You recently received instructions on how to access our proxy materials … to enhance rebates to payors and/or providers to improve reimbursement coverage for therapeutic indications, which we believe will provide better access
8-K
EX-10.1
tz9j1lzndxd4kx3iwuyd
19 Mar 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
gzphj
19 Mar 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.4
6qt3u
19 Mar 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
reys2plhs j1c8
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm